Yesterday, the SVP & CIO of HCA Healthcare (HCA), Martin Paslick, sold shares of HCA for $378.7K.
See today’s analyst top recommended stocks >>
The company has a one-year high of $151.97 and a one-year low of $58.38. HCA’s market cap is $44.78 billion and the company has a P/E ratio of 13.40.
Based on 16 analyst ratings, the analyst consensus is Strong Buy with an average price target of $144.19, reflecting a -7.1% downside. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy HCA with a $140.00 price target.
The insider sentiment on HCA Healthcare has been negative according to 87 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Martin Paslick’s trades have generated a 7.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. The company was founded by Dr. Thomas Frist Sr., Dr. Thomas Frist Jr., and Jack Massey in 1968 and is headquartered in Nashville, TN.
